1-13 of 13
Deanna M Grote
Close
Sort by
Journal Articles

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

Rebecca L. Boddicker, N. Sertac Kip, Xiaoming Xing, Yu Zeng, Zhi-Zhang Yang, Jeong-Heon Lee, Luciana L. Almada, Sherine F. Elsawa, Ryan A. Knudson, Mark E. Law, Rhett P. Ketterling, Julie M. Cunningham, Yanhong Wu, Matthew J. Maurer, Megan M. O’Byrne, James R. Cerhan, Susan L. Slager, Brian K. Link, Julie C. Porcher, Deanna M. Grote, Diane F. Jelinek, Ahmet Dogan, Stephen M. Ansell, Martin E. Fernandez-Zapico, Andrew L. Feldman
Journal: Blood
Blood (2015) 125 (20): 3118–3127.
https://doi.org/10.1182/blood-2014-05-578575
Published: 2015
Includes: Supplemental data
Journal Articles

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Deanna M. Grote, Steven C. Ziesmer, Lucy S. Hodge, PharmD, Ph.D., Tammy L. Price-Troska, Anne J. Novak, Ph.D., Zhi-Zhang Yang, MD, Stephen M Ansell, M.D.Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4334.
https://doi.org/10.1182/blood.V122.21.4334.4334
Published: 2013
Journal Articles

PD-1 Expression Defines Two Distinct T-Cell Subpopulations That Differentially Impact Patient Outcomes In Follicular Lymphoma

Zhi-Zhang Yang, MD, Deanna M. Grote, Steven C. Ziesmer, Stephen M Ansell, M.D.Ph.D.
Journal: Blood
Blood (2013) 122 (21): 366.
https://doi.org/10.1182/blood.V122.21.366.366
Published: 2013
Journal Articles

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

Sherine F. Elsawa, Anne J. Novak, Steven C. Ziesmer, Luciana L. Almada, Lucy S. Hodge, Deanna M. Grote, Thomas E. Witzig, Martin E. Fernandez-Zapico, Stephen M. Ansell
Journal: Blood
Blood (2011) 118 (20): 5540–5549.
https://doi.org/10.1182/blood-2011-04-351742
Published: 2011
Journal Articles

Soluble IL-2Rα facilitates IL-2–mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Zhi-Zhang Yang, Deanna M. Grote, Steven C. Ziesmer, Michelle K. Manske, Thomas E. Witzig, Anne J. Novak, Stephen M. Ansell
Journal: Blood
Blood (2011) 118 (10): 2809–2820.
https://doi.org/10.1182/blood-2011-03-340885
Published: 2011
Journal Articles

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

e-blood
Lucy S. Hodge, Anne J. Novak, Deanna M. Grote, Esteban Braggio, Rhett P. Ketterling, Michelle K. Manske, Tammy L. Price Troska, Steven C. Ziesmer, Rafael Fonseca, Thomas E. Witzig, William G. Morice, Morie A. Gertz, Stephen M. Ansell
Journal: Blood
Blood (2011) 117 (19): e190–e197.
https://doi.org/10.1182/blood-2010-12-326868
Published: 2011
Includes: Supplemental data
Journal Articles

Monocytes Promote Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma and Are Recruited to the Tumor Microenvironment by CCL5 (RANTES)

Ryan A Wilcox, MD, PhD, Wada A David, MD, Andrew L. Feldman, Sherine F Elsawa, Deanna M Grote, Steven C Ziesmer, Anne J Novak, Mark R. Pittelkow, Thomas E. Witzig, Stephen M Ansell
Journal: Blood
Blood (2008) 112 (11): 378.
https://doi.org/10.1182/blood.V112.11.378.378
Published: 2008
Journal Articles

B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenström macroglobulinemia

Sherine F. Elsawa, Anne J. Novak, Deanna M. Grote, Steven C. Ziesmer, Thomas E. Witzig, Robert A. Kyle, Stacey R. Dillon, Brandon Harder, Jane A. Gross, Stephen M. Ansell
Journal: Blood
Blood (2006) 107 (7): 2882–2888.
https://doi.org/10.1182/blood-2005-09-3552
Published: 2006
Journal Articles

Role of B-Lymphocyte Stimulator (BLyS) in Waldenstrom’s Macroglobulinemia.

Sherine F. Elsawa, PhD, Anne J. Novak, PhD, Deanna M. Grote, Steven C. Zeismer, Thomas E. Witzig, MD, Robert A. Kyle, MD, Stephen M. Ansell, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 601.
https://doi.org/10.1182/blood.V106.11.601.601
Published: 2005
Journal Articles

Lack of Increased Clinical Efficacy When Interleukin-12 Is Added to Rituximab in B-Cell Lymphoma Patients Is Related to Inadequate Delivery of the Cytokine to the Sites of Lymphoma.

Stephen M. Ansell, MD, Deanna M. Grote, BS, Thomas E. Witzig, MD, Anne J. Novak, PhD
Journal: Blood
Blood (2004) 104 (11): 1397.
https://doi.org/10.1182/blood.V104.11.1397.1397
Published: 2004
Journal Articles

B-Lymphocyte Stimulator (BLyS) Is Highly Expressed in Waldenstrom’s Macroglobulinemia.

Stephen M. Ansell, MD, PhD, Deanna M. Grote, BS, Steven C. Ziesmer, BS, Thomas E. Witzig, MD, Robert A. Kyle, MD, Anne J. Novak, PhD
Journal: Blood
Blood (2004) 104 (11): 2291.
https://doi.org/10.1182/blood.V104.11.2291.2291
Published: 2004
Journal Articles

Elevated BLyS Levels in Patients with Familial and Sporadic B-CLL: Correlation with BLyS Polymorphisms.

Anne J. Novak, PhD, Deanna M. Grote, Steven C. Ziesmer, Thomas E. Witzig, MD, Shanafelt Tait, MD, Timothy Call, MD, Neil E. Kay, MD, Diane F. Jelinek, PhD, James R. Cerhan, MD, PhD, Stephen M. Ansell, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 964.
https://doi.org/10.1182/blood.V104.11.964.964
Published: 2004
Journal Articles

Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome

Clinical Trials & Observations
Anne J. Novak, Deanna M. Grote, Mary Stenson, Steven C. Ziesmer, Thomas E. Witzig, Thomas M. Habermann, Brandon Harder, Kay M. Ristow, Richard J. Bram, Diane F. Jelinek, Jane A. Gross, Stephen M. Ansell
Journal: Blood
Blood (2004) 104 (8): 2247–2253.
https://doi.org/10.1182/blood-2004-02-0762
Published: 2004